EKF Diagnostics Holdings PLC Director/PDMR Shareholding (2221A)
May 28 2019 - 2:02AM
UK Regulatory
TIDMEKF
RNS Number : 2221A
EKF Diagnostics Holdings PLC
28 May 2019
EKF Diagnostics Holdings plc
("EKF", the "Company")
Director/PDMR Shareholding
EKF Diagnostics Holdings plc (AIM: EKF) announces that on 24 May
2019, the Company was notified by Adam Reynolds, Non-executive
Director, that he has today sold 400,000 ordinary shares of 1 pence
each in the capital of the Company ("Ordinary Shares").
EKF also announces that on the same date, it was notified by
Christopher Mills, Non-executive Chairman, that he has today
purchased 150,000 Ordinary Shares.
Following the above transactions, further details of which are
provided below, Adam Reynolds is now interested in 1,668,613
Ordinary Shares, representing 0.37% of the Company's issued share
capital and Christopher Mills is now interested in 136,113,591
Ordinary Shares in aggregate, representing 29.97% of the Company's
issued share capital.
Christopher Mills is a partner and Chief Investment Officer of
Harwood Capital LLP, which acts as an investment manager to Oryx
International Growth Fund Limited ("Oryx") and as an investment
adviser to the North Atlantic Smaller Companies Investment Trust
PLC ("NASCIT"), an investment trust. Oryx (of which Mr. Mills is
also a director and shareholder) holds 37,963,591 Ordinary Shares,
NASCIT holds 98,000,000 Ordinary Shares and 150,000 Ordinary Shares
are held directly by Mr. Mills.
EKF Diagnostics Holdings plc www.ekfdiagnostics.com
Christopher Mills, Non-Executive Chairman Tel: 029 2071 0570
Julian Baines, CEO
Richard Evans, FD & COO
N+1 Singer (Nomad & Broker) Tel: 020 7496 3000
Aubrey Powell / Lauren Kettle / George Tzimas
(Corporate Finance)
Tom Salveson (Corporate Broking)
Walbrook PR Limited Tel: 020 7933 8780 or ekf@walbrookpr.com
Paul McManus/ Lianne Cawthorne Mob: 07980 541 893 / 07584
391 303
Notification and public disclosure of transactions by persons
discharging managerial responsibilities and persons closely
associated with them
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Adam Reynolds
------------------------------ ---------------------------------------------------
2 Reason for the notification
-----------------------------------------------------------------------------------
a) Position/status Non-executive Director
------------------------------ ---------------------------------------------------
b) Initial notification Initial Notification
/Amendment
------------------------------ ---------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------------------
a) Name EKF Diagnostics Holdings plc
------------------------------ ---------------------------------------------------
b) LEI 213800DXTF3EAUK1AR05
------------------------------ ---------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been
conducted
-----------------------------------------------------------------------------------
a) Description of the Ordinary shares of 1p each ("Ordinary Shares")
financial instrument,
type of instrument
ISIN Code: GB0031509804
Identification code
------------------------------ ---------------------------------------------------
b) Nature of the transaction Sale of shares
------------------------------ ---------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
33. 0p 400,000
--------------
------------------------------ ---------------------------------------------------
d) Aggregated information n/a
- Aggregated volume
- Price
------------------------------ ---------------------------------------------------
e) Date of the transaction 24 May 2019
------------------------------ ---------------------------------------------------
f) Place of the transaction London Stock Exchange
------------------------------ ---------------------------------------------------
1 Details of the person discharging managerial responsibilities
/ person closely associated
a) Name Christopher Mills
------------------------------ ---------------------------------------------------
2 Reason for the notification
-----------------------------------------------------------------------------------
a) Position/status Non-executive Chairman
------------------------------ ---------------------------------------------------
b) Initial notification Initial Notification
/Amendment
------------------------------ ---------------------------------------------------
3 Details of the issuer, emission allowance market participant,
auction platform, auctioneer or auction monitor
-----------------------------------------------------------------------------------
a) Name EKF Diagnostics Holdings plc
------------------------------ ---------------------------------------------------
b) LEI 213800DXTF3EAUK1AR05
------------------------------ ---------------------------------------------------
4 Details of the transaction(s): section to be repeated for (i)
each type of instrument; (ii) each type of transaction; (iii)
each date; and (iv) each place where transactions have been
conducted
-----------------------------------------------------------------------------------
a) Description of the Ordinary shares of 1p each ("Ordinary Shares")
financial instrument,
type of instrument
ISIN Code: GB0031509804
Identification code
------------------------------ ---------------------------------------------------
b) Nature of the transaction Purchase of shares
------------------------------ ---------------------------------------------------
c) Price(s) and volume(s) Price(s) Volume(s)
33.1p 150,000
--------------
------------------------------ ---------------------------------------------------
d) Aggregated information n/a
- Aggregated volume
- Price
------------------------------ ---------------------------------------------------
e) Date of the transaction 24 May 2019
------------------------------ ---------------------------------------------------
f) Place of the transaction London Stock Exchange
------------------------------ ---------------------------------------------------
This information is provided by RNS, the news service of the
London Stock Exchange. RNS is approved by the Financial Conduct
Authority to act as a Primary Information Provider in the United
Kingdom. Terms and conditions relating to the use and distribution
of this information may apply. For further information, please
contact rns@lseg.com or visit www.rns.com.
END
DSHBIGDUDUDBGCR
(END) Dow Jones Newswires
May 28, 2019 02:02 ET (06:02 GMT)
EKF Diagnostics (AQSE:EKF.GB)
Historical Stock Chart
From Jun 2024 to Jul 2024
EKF Diagnostics (AQSE:EKF.GB)
Historical Stock Chart
From Jul 2023 to Jul 2024
